Evidence map›Paper›PMID 39013811›Full record

SynthesisZhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery2024

[Implementation and development of endoscopic benign breast lump resection and breast-conserving surgery for cancer].

Xuliren Wang, Min Xiong, Zhibo Shao, Bingqiu Xiu, Jiong Wu, Benlong Yang

Abstract readSystematic ReviewEnglish Abstract
In one paragraph

Synthesis in Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuliren WangDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Min XiongDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Zhibo ShaoDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Bingqiu XiuDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Jiong WuDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.
Benlong YangDepartment of Breast Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To review the development of endoscopic techniques in breast surgery, focusing on their use in benign breast lump resection and breast-conserving surgery for cancer, and also summarize the development and application of these techniques in China, highlighting promotion and homogenization challenges and future directions. Methods: A systematic review of relevant literature was conducted to trace the historical evolution, clinical applications, and related research of endoscopic techniques in breast surgery, emphasizing their advantages and disadvantages of endoscopic benign breast lump resection and breast-conserving surgery for cancer. Results: Endoscopic benign breast lump resection and breast-conserving surgery for cancer have improved patients' postoperative psychological health and quality of life, particularly in scar-free surgery. However, challenges such as limited intraoperative visibility and prolonged surgery time lead to controversy in clinical practice. Conclusion: Despite significant advancements, endoscopic techniques in breast surgery also face challenges. Future efforts should focus on technological improvements and clinical research to address these issues, promoting widespread application and standardization. The key to future development lies in the promotion and homogenization of these technologies.

Indexed as

Breast NeoplasmsEndoscopyMastectomy, SegmentalBreastChinaFemaleHumansQuality of Lifebreastbreast-conserving surgeryendoscopylump resectionMinimally invasive surgery

Identifiers

PMID39013811
PMCPMC11252680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.